WEBINAR ANNOUNCEMENT

Expressive Canvas: Optimize Creativity with Automated Facial Expression Recognition

Dr. Cyrus H. McCandless addresses the value and limitations of FACS, and emphasizes its utility to creative optimization in market research.

By Mia Noble
January 10, 2024

Unveiling FACS’ Potential for Brands

Event Overview

To elaborate on the findings presented in the latest Sentient Labs paper, “It’s Written All Over Your Face”, Sentient Decision Science will be hosting a webinar on Facial Action Coding. The event will be held virtually on Thursday, January 18th 2024 at 2:00PM EST.

Today, the use of Facial Action Coding enabled by AI systems, is a hotly-debated topic among the market research industry. Misunderstandings and misuse of the technology may prevent brands from realizing its potential. Under the appropriate conditions, FACS and advertisement testing are the perfect match—enabling researchers to accurately track and analyze real-time audience responses to media. Within this webinar, Sentient’s Dr. Cyrus H. McCandless  explains the value and limitations of Facial Action Coding, and emphasizes its utility to creative optimization.

Your Host

Dr. Aaron Reid
Dr. Cyrus H. McCandless
Chief Science Officer
Sentient Decision Science

What You’ll Learn:

  • The origins and evolution of FACS and how it provides insight into foundational principles for decoding facial expressions
  • Brands can tailor marketing strategies, content creation, and product development by utilizing FACS technology
  • A balanced perspective of its strengths and limitations in interpreting human facial expressions for MRX advantage

To learn more about how Sentient uses Automated Facial Action Coding to empower brands, check out our Emotion AI platform and schedule a demo!

Attend the Webinar

Registration required for the webinar.

Date: Thursday, January 18, 2024

Start Time: 2:00 PM EST | 11:00 AM PST

 

Mia Noble

By:

Creative Services Specialist

Archives

Categories

For more information about Sentient Decision Science and our groundbreaking research please contact us.